Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000216983 | SCV000277732 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-14 | criteria provided, single submitter | clinical testing | Synonymous alterations with insufficient evidence to classify as benign |
Labcorp Genetics |
RCV000464568 | SCV000554983 | likely benign | Neurofibromatosis, type 1 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000614768 | SCV000727314 | likely benign | not specified | 2018-02-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV000464568 | SCV002560188 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004547557 | SCV004786768 | likely benign | NF1-related disorder | 2023-02-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |